G Mani Subramanian Selected Research

Deuterium Oxide (Heavy Water)

1/2022	Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients.
1/2019	Discovery of Half-life of Circulating Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B Infection Using Heavy Water Labeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Mani Subramanian Research Topics

Disease

49	Infections 01/2020 - 04/2006
36	Fibrosis (Cirrhosis) 01/2022 - 10/2010
23	Chronic Hepatitis C 03/2019 - 01/2006
22	Chronic Hepatitis B 01/2020 - 02/2013
10	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
8	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 08/2011
6	Headache (Headaches) 10/2018 - 05/2013
5	Hepatitis C 01/2017 - 09/2012
4	Insulin Resistance 01/2022 - 10/2009
4	Inflammation (Inflammations) 01/2021 - 07/2011
4	Hepatitis B 01/2020 - 06/2013
3	Disease Progression 01/2021 - 01/2017
3	Nasopharyngitis 01/2020 - 11/2016
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 11/2016
3	Nausea 01/2017 - 05/2013
3	Fatigue 01/2017 - 05/2013
3	Virus Diseases (Viral Diseases) 12/2016 - 12/2007
2	Hepatitis 01/2021 - 01/2013
2	Pruritus (Itching) 01/2021 - 01/2020
2	Sclerosing Cholangitis 01/2021 - 01/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2020 - 01/2019
2	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2018 - 05/2013
2	Liver Diseases (Liver Disease) 01/2017 - 11/2014
2	Coinfection 03/2015 - 03/2015
2	HIV Infections (HIV Infection) 03/2015 - 07/2014
2	Anthrax 03/2012 - 07/2009
2	Shock 03/2012 - 12/2010
2	Body Weight (Weight, Body) 08/2011 - 07/2009
2	Edema (Dropsy) 03/2011 - 12/2010
2	Malaria 10/2002 - 02/2002
1	Cholangitis 02/2020

Drug/Important Bio-Agent (IBA)

22	SofosbuvirIBA 03/2019 - 05/2013
20	Antiviral Agents (Antivirals)IBA 01/2018 - 01/2006
19	InterferonsIBA 01/2019 - 01/2006
17	Ribavirin (Virazole)FDA LinkGeneric 10/2018 - 02/2009
15	Tenofovir (Viread)FDA Link 01/2020 - 02/2013
10	ledipasvirIBA 02/2016 - 03/2014
9	NucleotidesIBA 01/2020 - 05/2013
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
8	CollagenIBA 01/2021 - 01/2018
8	RNA (Ribonucleic Acid)IBA 03/2015 - 02/2009
8	Interferon-alpha (Interferon Alfa)IBA 02/2009 - 01/2006
7	Alanine Transaminase (SGPT)IBA 01/2021 - 10/2010
7	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 05/2014
7	Hepatitis B e AntigensIBA 01/2019 - 05/2014
7	albinterferon alfa-2bIBA 04/2012 - 06/2008
6	velpatasvirIBA 03/2019 - 12/2016
6	Proteins (Proteins, Gene)FDA Link 07/2014 - 02/2002
6	Human Serum Albumin FDA LinkGeneric 10/2010 - 01/2006
5	selonsertibIBA 01/2021 - 01/2018
5	tenofovir alafenamideIBA 01/2020 - 03/2015
4	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2020 - 10/2010
4	simtuzumabIBA 12/2019 - 01/2017
4	VaccinesIBA 01/2019 - 10/2002
4	vesatolimodIBA 01/2018 - 01/2013
4	Emtricitabine (Emtriva)FDA Link 01/2017 - 06/2013
4	sofosbuvir drug combination ledipasvirIBA 04/2015 - 05/2014
3	firsocostatIBA 01/2021 - 11/2018
3	cilofexorIBA 01/2021 - 01/2019
3	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2016
3	AntigensIBA 01/2019 - 07/2009
3	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2018 - 01/2017
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 07/2014
3	GS-9451IBA 02/2016 - 07/2014
3	Interferon alpha-2 (Roferon-A)FDA Link 10/2010 - 08/2008
3	AlbuminsIBA 01/2008 - 01/2006
3	albumin interferonIBA 01/2008 - 01/2006
2	Deuterium Oxide (Heavy Water)IBA 01/2022 - 01/2019
2	nasIBA 01/2021 - 12/2019
2	Alkaline PhosphataseIBA 01/2021 - 02/2020
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2020 - 01/2019
2	MAP Kinase Kinase Kinase 5IBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 03/2015
2	Peptides (Polypeptides)IBA 01/2019 - 10/2010
2	ProteomeIBA 01/2019 - 01/2019
2	Monoclonal AntibodiesIBA 10/2018 - 03/2011
2	TabletsIBA 01/2018 - 04/2014
2	voxilaprevirIBA 01/2017 - 01/2017
2	Lamivudine (Epivir)FDA Link 01/2017 - 04/2014
2	CreatinineIBA 11/2016 - 11/2014
2	GS-9669IBA 02/2016 - 03/2014
2	Toll-Like Receptor 7IBA 01/2015 - 01/2013
2	NucleosidesIBA 07/2014 - 03/2014
2	Recombinant ProteinsIBA 05/2009 - 08/2008
1	VLDL LipoproteinsIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	PalmitatesIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Biological ProductsIBA 01/2021
1	BilirubinIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Drug CombinationsIBA 01/2021
1	Keratin-18 (Keratin 18)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	EnzymesIBA 01/2020

Therapy/Procedure

26	Therapeutics 01/2021 - 01/2006
2	Transplantation 02/2020 - 01/2015
2	Aftercare (After-Treatment) 10/2018 - 01/2018
2	Liver Transplantation 01/2015 - 06/2013